{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363670318879533568.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1093/brain/awh127"}},{"identifier":{"@type":"URI","@value":"http://academic.oup.com/brain/article-pdf/127/5/1085/859623/awh127.pdf"}}],"dc:title":[{"@value":"Anti-ganglioside antibody-mediated neuronal cytotoxicity and its protection by intravenous immunoglobulin: implications for immune neuropathies"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1380004237554782218","@type":"Researcher","foaf:name":[{"@value":"G. Zhang"}]}],"publication":{"publicationIdentifier":[{"@type":"EISSN","@value":"14602156"}],"prism:publicationName":[{"@value":"Brain"}],"dc:publisher":[{"@value":"Oxford University Press (OUP)"}],"prism:publicationDate":"2004-02-26","prism:volume":"127","prism:number":"5","prism:startingPage":"1085","prism:endingPage":"1100"},"reviewed":"false","url":[{"@id":"http://academic.oup.com/brain/article-pdf/127/5/1085/859623/awh127.pdf"}],"createdAt":"2004-03-04","modifiedAt":"2017-08-22","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1360004237554782080","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Different IVIG Glycoforms Affect In Vitro Inhibition of Anti-Ganglioside Antibody-Mediated Complement Deposition"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282680011439232","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Immune-mediated neuropathy"},{"@language":"ja","@value":"シンポジウム１１‐２　末梢神経障害の研究‐最近の進歩‐　免疫関連性ニューロパチー"},{"@value":"免疫関連性ニューロパチー"},{"@language":"ja-Kana","@value":"メンエキ カンレンセイ ニューロパチー"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1093/brain/awh127"},{"@type":"CROSSREF","@value":"10.1371/journal.pone.0107772_references_DOI_5YgUYxxHvacgA7d6CkAy4fXofv1"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.48.1023_references_DOI_5YgUYxxHvacgA7d6CkAy4fXofv1"}]}